XL-protein and Antlia Bioscience announce collaboration to develop long-acting peptide therapy of chronic heart failure using PASylation® Technology
October 15, 2020
October 15, 2020
July 7, 2020
March 23, 2020
February 26, 2020
February 11, 2020
February 7, 2020
February 6, 2020
February 3, 2020
February 3, 2020
April 17, 2026
Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high ...
April 15, 2026
The Board of Directors of Medix Biochemica, a global leader in the supply of mission critical components for the in vitro diagnostics (IVD) industry, ...
April 14, 2026
Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s diseas...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225